Monn JA - Search Results

1

Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing.

Jones CK, Eberle EL, Peters SC, Monn JA, Shannon HE. Jones CK, et al. Among authors: monn ja. Neuropharmacology. 2005;49 Suppl 1:206-18. doi: 10.1016/j.neuropharm.2005.05.008. Neuropharmacology. 2005. PMID: 15998527

2

Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia.

Fell MJ, McKinzie DL, Monn JA, Svensson KA. Fell MJ, et al. Among authors: monn ja. Neuropharmacology. 2012 Mar;62(3):1473-83. doi: 10.1016/j.neuropharm.2011.06.007. Epub 2011 Jun 21. Neuropharmacology. 2012. PMID: 21704048 Review.

3

Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740.

Orlando R, Borro M, Motolese M, Molinaro G, Scaccianoce S, Caruso A, di Nuzzo L, Caraci F, Matrisciano F, Pittaluga A, Mairesse J, Simmaco M, Nisticò R, Monn JA, Nicoletti F. Orlando R, et al. Among authors: monn ja. Neuropharmacology. 2014 Nov;86:133-44. doi: 10.1016/j.neuropharm.2014.07.009. Epub 2014 Jul 22. Neuropharmacology. 2014. PMID: 25063582

4

In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu_2/3 receptor antagonist.

Witkin JM, Ornstein PL, Mitch CH, Li R, Smith SC, Heinz BA, Wang XS, Xiang C, Carter JH, Anderson WH, Li X, Broad LM, Pasqui F, Fitzjohn SM, Sanger HE, Smith JL, Catlow J, Swanson S, Monn JA. Witkin JM, et al. Among authors: monn ja. Neuropharmacology. 2017 Mar 15;115:100-114. doi: 10.1016/j.neuropharm.2015.12.021. Epub 2015 Dec 31. Neuropharmacology. 2017. PMID: 26748052

5

Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice.

O'Neill MF, Heron-Maxwell C, Conway MW, Monn JA, Ornstein P. O'Neill MF, et al. Among authors: monn ja. Neuropharmacology. 2003 Oct;45(5):565-74. doi: 10.1016/s0028-3908(03)00232-6. Neuropharmacology. 2003. PMID: 12941370

6

LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors.

Schoepp DD, Johnson BG, Wright RA, Salhoff CR, Mayne NG, Wu S, Cockerman SL, Burnett JP, Belegaje R, Bleakman D, Monn JA. Schoepp DD, et al. Among authors: monn ja. Neuropharmacology. 1997 Jan;36(1):1-11. doi: 10.1016/s0028-3908(96)00160-8. Neuropharmacology. 1997. PMID: 9144636

7

LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats.

Helton DR, Tizzano JP, Monn JA, Schoepp DD, Kallman MJ. Helton DR, et al. Among authors: monn ja. Neuropharmacology. 1997 Nov-Dec;36(11-12):1511-6. doi: 10.1016/s0028-3908(97)00170-6. Neuropharmacology. 1997. PMID: 9517421

8

Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade.

Cartmell J, Perry KW, Salhoff CR, Monn JA, Schoepp DD. Cartmell J, et al. Among authors: monn ja. Neuropharmacology. 2001 Jun;40(7):847-55. doi: 10.1016/s0028-3908(01)00034-x. Neuropharmacology. 2001. PMID: 11378155

9

Pharmacological agents acting at subtypes of metabotropic glutamate receptors.

Schoepp DD, Jane DE, Monn JA. Schoepp DD, et al. Among authors: monn ja. Neuropharmacology. 1999 Oct;38(10):1431-76. doi: 10.1016/s0028-3908(99)00092-1. Neuropharmacology. 1999. PMID: 10530808 Review.

10

Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR.

Sanger H, Hanna L, Colvin EM, Grubisha O, Ursu D, Heinz BA, Findlay JD, Vivier RG, Sher E, Lodge D, Monn JA, Broad LM. Sanger H, et al. Among authors: monn ja. Neuropharmacology. 2013 Mar;66:264-73. doi: 10.1016/j.neuropharm.2012.05.023. Epub 2012 May 30. Neuropharmacology. 2013. PMID: 22659090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page